Kelly Paul Edward

EDGAR CIK 0001658544

Relmada Therapeutics, Inc. - RLMD

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director
Direct Buys
1
$64,750
25,000 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
09/09/2024
09/11/2024
Buy
25,000 @ $2.59
 $64,750 212,295 (13.35%) Direct